Ceraxon ampoules intravenously, intramuscularly1000mg/4ml №5

Use - Acute phase of ischemic stroke (as part of complex therapy). - Recovery period of ischemic and hemorrhagic strokes. - Traumatic brain injury, acute (as part of complex therapy) and recovery period. - Cognitive and behavioral disorders in degenerative and vascular diseases of the brain. How to take - The drug is administered intravenously or intramuscularly. - The recommended dose is 500-2000 mg/day. The dose and duration of treatment depend on the severity of the disease symptoms. - Intravenously, the drug is administered as a slow intravenous injection (over 3-5 minutes, depending on the prescribed dose) or a continuous intravenous infusion (40-60 drops per minute). - The intravenous route of administration is preferred over the intramuscular route. When administering intramuscularly, repeated administration of the drug to the same site should be avoided. - In the acute period of ischemic stroke and traumatic brain injury, the recommended dose is 1000 mg every 12 hours from the first day after diagnosis; the duration of treatment is at least 6 weeks. - After 3-5 days of treatment (if swallowing function is not impaired), it is possible to switch to oral forms of Ceraxon. Contraindications - Severe vagotonia (prevalence of parasympathetic nervous system tone). - Children and adolescents under 18 years of age (due to insufficient clinical data). - Hypersensitivity to the components of the drug used.